serological

[키워드] age All participant All participants antibody Antibody Response Antibody titer approved average BNT162b2 center Clinical data Control controls COVID-19 COVID-19 infection dose Efficacy elicited enrolled Factor female filtration rate glomerular filtration rate healthy healthy controls healthy volunteer healthy volunteers High dose IgG IgG antibodies Immunity immunogenicity Immunological response immunosuppressive medications include less levels of antibody liver liver transplant Liver transplantation medical records mRNA vaccine mRNA-based vaccine mycophenolate mycophenolate mofetil N-protein nucleocapsid Older age Patient Pfizer Pfizer-BioNTech Pfizer-BioNTech BNT162b2 positive positive serology Prevent receiving recipient recipients regimen renal function reported risk S-protein SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serious Adverse Event Serious Adverse Events serological serology Side effect significantly lower Special Population spike-protein steroid Steroids tested the patient Treatment trials vaccination Vaccine vaccine immunogenicity virus was collected
[DOI] 10.1016/j.jhep.2021.04.020 PMC 바로가기 [Article Type] Article